- Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma2021 | First Faculty of Medicine
- Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma2020 | First Faculty of Medicine, Second Faculty of Medicine
- Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells are Regulated by LCK and Independent of LATS Activity2018 | Publication without faculty affiliation
- Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma2018 | Faculty of Medicine in Hradec Králové
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine
- Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative2017 | First Faculty of Medicine
- Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport